Liu, L., Li, S., Qu, H., Yu, W., Zhang, X., Li, P., Cui, X., Wei, M., Zhang, D., Ma, M., Hu, J., Wang, C., Xia, B. (2025). Feasibility of circulating tumor DNA-based minimal residual disease (ctDNA-MRD)-guided adjuvant chemotherapy in patients with stage II-III gastric cancer (GC): An adaptive trial (MRD-GATE).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4061